"Women's Radio Network Open Forum" To Feature AxoGen, Inc. CMO Jill Schiaparelli Discussing Women Suffering from Nerve Injuries and Options for Repair
Live Interview Airs April 23, 2015, Hosted by Lisa Singer,2:00pm ET | 1:00pm CT | 11:00am PT
ALACHUA, FL, April 23, 2015 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company dedicated to peripheral nerve repair, announced today that Chief Marketing Officer Jill Schiaparelli will be interviewed live on a special afternoon segment of Women’s Radio Network Open Forum, hosted by Lisa Singer. In this exclusive interview, Ms. Schiaparelli will discuss AxoGen’s focus on helping people living with nerve damage, methods of diagnosis and new options for repair. Joining Jill will be special guest and patient Shirley Pincus, one of thousands of women who suffered from debilitating pain as a result of an undiagnosed nerve injury.
After more than 5 years of living day to day with pain, Shirley found a doctor who was able to identify that her pain was being caused by a nerve injury from decades earlier. Shortly after, her doctor performed a surgical procedure to remove the damaged nerve tissue from three places in Shirley’s leg and repair it with AxoGen’s Avance® Nerve Graft, processed donated human nerve tissue. Thanks to her perseverance, a proper diagnosis, expert surgeons, physical therapy and the generous donation of nerve tissue, Shirley is returning to everyday activity and is regaining her quality of life.
All shareholders, analysts, industry professionals are encouraged to listen to the live broadcast to hear more about Shirley’s story and new options for repairing damaged nerves. See details below.
Date: Thursday, April 23, 2015
Start Time: 2:00pm ET| 1:00pm CT | 11:00am PT
Network: Women’s Radio Network – iHeart Radio
Station: WRNW1 1100 AM
Show: Women’s Radio Network Open Forum - Special Afternoon Edition
Host: Lisa Singer
Live Stream: http://www.wrnw1.com/djs/lisa/
About “Women’s Radio Network”
Women’s Radio Network, “WRN”, is a global, networking community for women professionals and entrepreneurs. Women’s Radio Network offers interviews with the innovative, creative and successful women. Our interviewees tell their personal stories, share ideas and provide mentoring to fellow WRNW1 listeners regarding tenacity, leadership, motivation, ingenuity and overcoming obstacles.
Join us while we celebrate you, and women like you as we broadcast their stories on Women’s Radio Network, WRNW1.COM.
About Women’s Radio Network Open Forum with Lisa Springer
Open Forum with Lisa Singer broadcasts normally broadcasts Monday through Friday, 9AM-12PM EST. Live interviews with executive and professional women across the globe.
About Lisa Singer
Award winning journalist Lisa Singer is a proven talent as a host, reporter, producer and writer for a multitude of media outlets that include WireImage Video, IntheKnowGuide, HSN, E! Entertainment Television, TNT and Court TV’s “Hollywood Heat.” She’s been at the center of all things entertainment; reporting breaking news, interviewing Hollywood’s biggest stars and covering the industry’s most glamorous, red carpet events…including the Academy Awards, Emmys, blockbuster movie premieres and the prestigious Director’s Guild Awards, among others. Lisa is also a contributing writer for Global Animal where she writes a lifestyle blog sharing tips and recipes for healthier and more compassionate eating.
Lisa and her dog Monty are a certified therapy team, volunteering at hospitals, senior centers and libraries where they help children read. A native of Massachusetts, she graduated from Boston University with a Bachelor of Arts degree in Broadcast Journalism.
About AxoGen, Inc.
AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.
To learn more about AxoGen and to sign up for news alerts, visit www.AxoGenInc.com.
Cautionary Statement Concerning Forward-Looking Statements
This Press Release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations or predictions of future conditions, events or results based on various assumptions and management's estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", "projects", "forecasts", "continue", "may", "should", "will" variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding our growth, our product development and product potential. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect AxoGen's business and its market, particularly those discussed in the risk factors and cautionary statements in AxoGen's filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected. The forward-looking statements are representative only as of the date they are made, and, except as required by law, AxoGen assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Released April 23, 2015